Benson Hill Inc. has reached a significant milestone in its Chapter 11 bankruptcy proceedings. On May 22, 2025, the United States Bankruptcy Court for the District of Delaware approved the sale of substantially all of Benson Hill's assets. The court authorized the Asset Sale to Confluence Genetics, LLC, which includes entities affiliated with S2G Investments, LLC, and ProAgInvest, LLC. This sale was executed under a Bankruptcy Court-approved asset purchase agreement. The agreement encompasses the assumption of certain liabilities and a cash payment to cover closing costs, contractual obligations, and a $1 million wind-down amount. Additionally, the transaction involves the settlement of the $11 million debtor-in-possession credit facility. The approval marks a crucial step in Benson Hill's restructuring process, as the company continues to operate as a debtor-in-possession while pursuing a resolution to its financial challenges.